Solid Biosciences (SLDB) Shareholder's Equity Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.06% |
| Dec 31, 2025 | 31.16% |
| Sep 30, 2025 | 30.49% |
| Jun 30, 2025 | 33.66% |
| Mar 31, 2025 | 39.74% |
| Dec 31, 2024 | 8.51% |
| Sep 30, 2024 | 15.70% |
| Jun 30, 2024 | 18.03% |
| Mar 31, 2024 | 14.66% |
| Dec 31, 2023 | -40.25% |
| Sep 30, 2023 | 0.76% |
| Jun 30, 2023 | 0.92% |
| Mar 31, 2023 | -0.93% |
| Dec 31, 2022 | 1.66% |
| Sep 30, 2022 | -35.86% |
| Jun 30, 2022 | -31.82% |
| Mar 31, 2022 | -26.68% |
| Dec 31, 2021 | 57.63% |
| Sep 30, 2021 | 904.74% |
| Jun 30, 2021 | 484.43% |
| Mar 31, 2021 | 348.14% |
| Dec 31, 2020 | 65.01% |
| Sep 30, 2020 | -79.52% |
| Jun 30, 2020 | -46.78% |
| Mar 31, 2020 | -43.04% |
| Dec 31, 2019 | -36.06% |
| Sep 30, 2019 | -25.19% |
| Jun 30, 2019 | -52.87% |
| Mar 31, 2019 | -44.61% |
| Dec 31, 2018 | 311.25% |